The polyketide synthase (PKS) mega-enzyme assembly line uses a modular architecture to synthesize diverse and bioactive natural products that often constitute the core structures or complete chemical entities for many clinically approved therapeutic agents 1 . The architecture of a full-length PKS module from the pikromycin pathway of Streptomyces venezuelae creates a reaction chamber for the intramodule acyl carrier protein (ACP) domain that carries building blocks and intermediates between acyltransferase, ketosynthase and ketoreductase active sites (see accompanying paper 2 ). Here we determine electron cryo-microscopy structures of a full-length pikromycin PKS module in three key biochemical states of its catalytic cycle. Each biochemical state was confirmed by bottom-up liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry. The ACP domain is differentially and precisely positioned after polyketide chain substrate loading on the active site of the ketosynthase, after extension to the b-keto intermediate, and after b-hydroxy product generation. The structures reveal the ACP dynamics for sequential interactions with catalytic domains within the reaction chamber, and for transferring the elongated and processed polyketide substrate to the next module in the PKS pathway. During the enzymatic cycle the ketoreductase domain undergoes dramatic conformational rearrangements that enable optimal positioning for reductive processing of the ACP-bound polyketide chain elongation intermediate. These findings have crucial implications for the design of functional PKS modules, and for the engineering of pathways to generate pharmacologically relevant molecules.
| Cryo-EM structure of pentaketide-KS 5 -PikAIII. a, Solid rendering (left) and transparent representation with modelled structures (right) of the pentaketide-KS 5 -PikAIII cryo-EM map. b, Interface of AT 12 and ACP 14 docked within the cryo-EM density. ACP helix 2 (residues 1439-1452) contacts the two AT lid helices (residues 701-709 and 732-744). The phosphopantetheinylated Ser 1438 of ACP is 35 Å from the AT active site.
c, Comparison of the KR structure 13 docked in the cryo-EM map for holo-PikAIII and pentaketide-KS 5 -PikAIII. The dramatic rearrangement upon pentaketide-KS formation brings two helices (residues 1126-1138, 1156-1166) of the KR catalytic subdomain (KR cat , magenta) in contact with an AT helix (residues 760-775) and moves the structural subdomain of KR (KR struc , purple) away from AT. However, many combinatorial biosynthesis efforts have been beset by problems of inefficiency and a limited ability to display 'plug and play' behaviour [6] [7] [8] . Thus, there is a critical need to dissect and understand the bacterial type I PKS module architecture and its conformational dynamics during polyketide chain elongation and processing.
Each module in the bacterial type I PKS catalyses the elongation of an intermediate by two carbon atoms in a linear sequence, and may also modify the intermediate by reductive processing or b-branching 9 . An ACP domain within each module shuttles extender units and polyketide chain elongation intermediates between the catalytic domains. In an accompanying paper 2 , we describe the overall architecture of PKS module 5 (PikAIII) from the pikromycin pathway (Pik) 10 . This PKS module is organized around a dimeric ketosynthase (KS) domain and a central chamber for the ACP, with the active sites of catalytic domains facing the chamber. Here we examined the dynamics of the PikAIII module 5 ACP (ACP 5 ) within the reaction chamber of PikAIII to probe its localization and underlying protein-protein interactions during the catalytic cycle. Within PikAIII, the acyltransferase (AT 5 ) loads ACP 5 with a methylmalonyl (MM) extender unit, and the KS (KS 5 ) catalyses a decarboxylative condensation reaction between the MM group and the pentaketide delivered by the module 4 ACP to produce a b-ketohexaketide intermediate. The b-hydroxyhexaketide product is subsequently generated through NADPH-dependent reduction by the ketoreductase (KR 5 ) domain of PikAIII.
Incubation of full-length holo-PikAIII with thiophenol-activated pentaketide 11 generated pentaketide-PikAIII, in which this natural substrate was bound to the catalytic Cys 209 of KS 5 (Extended Data Fig. 1a -c). The three-dimensional electron cryo-microscopy (cryo-EM) map of pentaketide-KS 5 -PikAIII was calculated at a resolution of 7.9 Å (Extended Data Fig. 2a, d ), enabling precise docking of the structures of 6-deoxyerythronolide B synthase (DEBS) module 5 KS and AT 12 , DEBS module 1 KR 13 , and DEBS module 2 ACP 14 . This EM reconstruction revealed several striking conformational changes compared to the structure of holo-PikAIII ( Fig. 1a) 2 . The AT 5 moves towards KS 5 by ,2 Å and partially occludes the side entrance to the KS 5 active site (Extended Data Fig. 3a ), which may sequester the labile polyketide intermediate until the extension reaction occurs. In addition, several loops on the KS surface appear to have changed position and additional densities appear at the bottom of the KS, below the catalytic Cys 209 (Extended Data Fig. 3a, b ). These KS conformational changes upon pentaketide loading on Cys 209 may be allosterically sensed by the AT domains, leading to the AT 5 shift. Pentaketide-induced conformational changes are also evident in the position of ACP 5, which shifts 10 Å and 30 Å towards AT 5 from its positions in the two holo-PikAIII conformers 2 . In this position ACP 5 appears to insert helix 2 between the two helices of the AT 5 lid subdomain (Fig. 1b ). The interaction requires small conformational changes to one or both domains, although the details are not discernable in the EM maps. The reactive Ser 1438 of ACP 5 is directed towards the AT 5 active site, presumably poising the ACP for loading with the MM extender unit by the AT domain. We probed the ACP-AT interface with single alanine substitutions in AT 5 of the PikAIII-TE protein used for functional assays 15, 16 (PikAIII fused to PikAIV TE, the module 6 thioesterase domain). AT 5 Glu 735 is in the ACP 5 contact zone, while Arg 747, approximately 20 Å from the AT 5 active site, was predicted to reside in the ACP docking site of a DEBS AT 17 . Consistent with the cryo-EM results, the E735A or the R747A PikAIII-TE mutants exhibited tenfold and fivefold reduced formation of the 10deoxymethynolide (10-dml) macrolactone product, respectively (Extended Data Fig. 4 ).
The most surprising feature of the pentaketide-KS 5 -PikAIII structure is that KR 5 has undergone an end-to-end flip compared to the holo-PikAIII reconstruction (Fig. 1c ). This finding suggests that the pentaketideinduced repositioning of AT 5 and ACP 5 also affects the AT 5 -KR 5 linker, causing the large rotation of KR 5 . The end-to-end flip does not tangle the PikAIII topology, as the linker connections (residues 916 and 1360) are adjacent in KR 5 and reside at the junction of the structural (KR 5struc ) 
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and catalytic (KR 5cat ) subdomains. The ,180u KR 5 rotation positions the catalytic domain proximal to AT 5 , with the AT 5 -KR 5 interface formed by an AT 5 helix and two KR 5cat helices. Specifically, KR 5 Arg 1133 and His 1137 are positioned to interact with AT 5 Glu 766 or Glu 768. We confirmed the importance of the KR 5cat -AT 5 interface for catalytic function with R1133E, H1137E, E766R and E768R substitutions, which had 2-to 15-fold reduced activity relative to the wild-type PikAIII-TE (Extended Data Fig. 4 ). By contrast, substitution of a KR 5struc residue at the KR 5struc -AT 5 interface of holo-PikAIII had no impact on production of 10-dml 2 . The end-to-end KR 5 flip, together with the unrelated repositioning of KR 5 observed upon ACP 5 deletion 2 , indicates that its orientation depends on the state of other PikAIII domains.
To characterize the architecture of PikAIII, in which the b-ketohexaketide chain elongation intermediate is tethered to ACP 5 , we incubated holo-PikAIII with both MM-coenzyme A (CoA) and thiophenol-activated pentaketide (Extended Data Fig. 1d -i). The three-dimensional cryo-EM structure of b-ketohexaketide-PikAIII at 7.8 Å resolution (Extended Data Fig. 2b, d ) reveals the same overall PikAIII conformation of the catalytic domains as observed for pentaketide-KS 5 -PikAIII, with the KR 5 catalytic domain proximal to AT 5 (Fig. 2a ). Furthermore, in the bketohexaketide-PikAIII structure, AT 5 is shifted towards KS 5 by 8 Å compared with the holo state and occludes the KS 5 side entrance ( Fig. 2b ), probably preventing intermediate transfer from the upstream PikAII ACP 4 to the KS 5 active site.
KR domains catalyse the NADPH-dependent reduction of the b-keto group to form either a D-(B-type KR) or L-(A-type KR) hydroxyl group. To form the two hydroxyl group stereochemistries, A-and B-type KRs are proposed to guide substrates into their active sites from opposite directions 18, 19 through the differential ordering of the KR 'lid loop' and 'lid helix' upon cofactor and substrate binding 20 . The b-ketohexaketide ACP 5 docks with the 'lid helix' and 'lid loop' of the A-type KR 5 , with ACP 5 Ser 1438 pointing towards the KR 5 active site at a distance of 19 Å (Fig. 2c ). Given the long linker between KR and ACP (43 amino acids), it is unclear whether ACP 5 interacts with the KR 5 of the same or the opposite monomer. An R1308E substitution in the KR 5 lid helix reduced activity tenfold compared with wild type, validating the observed docking site (Extended Data Fig. 4a, b ). From this position, a b-keto ACP substrate can enter the KR active site from either direction, facilitating formation of b-hydroxy products of KR-specified chirality 19 . Thus, the observed ACP docking site on the KR is a general solution for PKS modules with either A-or B-type KRs.
To form b-hydroxyhexaketide-PikAIII, we incubated holo-PikAIII with MM-CoA, thiophenol-activated pentaketide and NADPH (Extended Data Fig. 1j ), and applied cryo-EM to obtain its structure. During initial three-dimensional reconstructions we observed three different positions for ACP 5 and applied multiple-reference-supervised classification to calculate three independent three-dimensional reconstructions at resolutions of ,11 Å ( Fig. 3a and Extended Data Fig. 2c, d) 21, 22 . In all three conformers the catalytic domains are identically positioned, with the KS 5 side entrance occluded and the KR 5 domain oriented with its active site proximal to AT 5 , as is the case with the pentaketide-PikAIII and bketohexaketide-PikAIII structures. In each conformer the ACP 5 domains are below the KR 5struc and completely outside the catalytic chamber (Fig. 3b ). The ACP structure can be precisely docked within each corresponding density in all three states, indicating that the three positions are highly populated and that ACP 5 is not particularly flexible under these conditions (Fig. 3b, c) . In these configurations, Ser 1438 of ACP 5 points away from PikAIII, which is fully compatible with ACP 5 docking 
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to the KS 6 side entrance of PikAIV for substrate transfer 2 . This demonstrates the mechanism to maintain the directionality of PKS pathways, because only when the substrate is completely modified is the ACP ejected from the reaction chamber and positioned for transfer to the next module ( Fig. 4 ). Consistent with this mechanism, when NADPH was excluded from a coupled PikAIII/PikAIV assay 15 , thus preventing b-hydroxyhexaketide formation, substrate consumption was halved, indicating that intermediate transfer from PikAIII to PikAIV is impaired when ACP is sequestered within the reaction chamber (Extended Data Fig. 5 ).
Our studies capture the travels of PikAIII ACP 5 in the reaction chamber of a complete PKS module and reveal a stunning ACP localization dependent on the identity of the phosphopantetheine-linked polyketide intermediate or extender unit (Fig. 4) . The cryo-EM structures identified interaction surfaces for ACP 5 on each of the catalytic domains, differing in all cases from predicted sites, and confirmed by site-directed mutagenesis. The interacting surfaces of ACP 5 are generally chargecomplementary with partner catalytic domains, and similar to those recently observed in other ACP-enzyme interactions 2,23-25 . Interestingly, ACP 5 does not engage in specific protein-protein interactions with catalytic domains unless the appropriate substrate is loaded, indicating that tethered substrate is a primary determinant of ACP 5 localization. However, the high level of ordering observed for ACP does not apply to the post-ACP elements. The post-ACP helices, while essential for PikAIII dimerization, do not appear to be in a fixed position relative to the other PikAIII domains, suggesting that docked or fused downstream modules would also not assume a fixed position relative to the upstream module. Remarkably, the cryo-EM structures also demonstrate the existence of interdomain cross-talk within the module, evidenced both by the end-to-end flip of the KR 5 that positions its active site to interact with the b-ketohexaketide-loaded ACP and by movements of AT 5 that appear to limit access to the KS 5 active-site side entrance. Both structural transitions occur when the module contains pentaketide or hexaketide intermediates, indicating that the operation of the assembly line sets the conformational state of the PKS module and positions the domains for the next catalytic step. This clever design of the PKS module leads to optimal throughput, in which substrate availability and the rates of catalysis, rather than transfer rates, are probably the limiting steps in the catalytic cycle of type I modular megasynthases. The striking influence of substrate in the positioning and orientation of ACP, KR and AT has profound implications for the design of PKS modules. Although considerable optimization may be needed in adapting modules to unnatural substrates or in developing effective combinatorial biosynthesis approaches, the detailed insights revealed in this study provide a new structural framework from which to pursue these efforts.
METHODS SUMMARY
PikAIII for cryo-EM analysis was purified by Ni-affinity chromatography followed by duplicate gel filtration steps. To trap PikAIII in different states, the purified proteins were incubated with substrate, and adsorbed on holey carbon grids followed by blotting and vitrification. Bottom-up liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry (LC/FT-ICR MS) confirmed substrate loading onto the PikAIII variants. All specimens were imaged on a Tecnai F20 transmission electron microscope (FEI) equipped with a field emission gun operated at 120 kV. Images were recorded at a magnification of 366,964 on a Gatan US4000 CCD camera and defocus values ranging from 21.5 to 23.5 mm. EMAN routines were used for particle picking, generation of an initial model, and model refinement. Crystal structures of domains were independently fit in the EM maps as rigid bodies. Functional assays that require intermediate processing by PikAIII detected TE-offloaded products from PikAIII-TE or PikAIII/PikAIV 15, 16 .
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Design of expression constructs. Construction of expression plasmids for PikAIII (pPikAIII) and PikAIV (pPikAIV) 26 and for PikAIII fused to PikAIV TE (pPikAIII-TE) 27 was described previously. Mutations of PikAIII-TE were made with sitedirected mutagenesis using the QuikChange Lightning multi-site kit (Strategene). All DNA constructs were confirmed with sequencing. Primers used for site directed mutagenesis are as follows (underlined text indicates mutated base pairs in the site-directed mutagenesis primers). PikAIIIR747A, TGCGAGGCCGACGGCGT CGCTGCGCGGATCATCCCGGTC; PikAIIIE735A, GGCGACCCGACCCAG ATCGCGGAACTCGCCCGCACCTGC; PikAIIIE766R, CGGCAGGTCGAGA TCATCAGGAAGGAGCTGGCCGAGGTC; PikAIIIE768R, GTCGAGATCAT CGAGAAGAGGCTGGCCGAGGTCCTCGCC; PikAIIIR1133E, CTCGGCAGC CACGCCGCAGAGTGGATGGCCCACCACGGA; PikAIIIH1137E, GCCGCA CGCTGGATGGCCGAGCACGGAGCCGAACACCTC; PikAIIIR1308E, GACG ACGCGTACTGGCAGGAGCGCGGCATCCGTCCGATG. Expression and purification. All expression plasmids were expressed in E. coli Bap1 (ref. 28 ) cells to produce holo ACP. Transformed bacteria were cultured at 37 uC to an OD 600 nm 5 1 in 0.5 l of TB media with 50 mg ml 21 kanamycin. After incubation at 20 uC for 1 h, cells were induced with 200 mM isopropyl-b-D-thiogalactoside (IPTG) and allowed to express for approximately 18 h. Cell pellets were re-suspended in 50 mM HEPES pH 7.4 (buffer A), 300 mM NaCl, 10% glycerol containing 0.1 mg ml 21 lysozyme, 0.05 mg ml 21 DNase, 2 mM MgCl 2 and 20 mM imidazole. Cells were lysed by sonication, centrifuged, and the supernatant was loaded onto a 5 ml HisTrap column (GE Healthcare). A gradient of 15-300 mM imidazole in buffer A over 10 column volumes was used to elute the proteins.
For the PikAIII, PikAIV and PikAIII-TE proteins used in activity assays, the peak fractions from the HisTrap column were dialysed overnight into buffer A to remove imidazole and frozen. For PikAIII proteins analysed with EM, peak fractions from the His column were collected and further purified with a HiPrep 16/60 Sephacryl S300 HR column in buffer A. The peak fractions from the first gel filtration column were collected and further purified on a second HiPrep 16/60 Sephacryl S300 HR column. Substrate loading of PikAIII constructs. All proteins were dialysed into 50 mM HEPES pH 7.4, 100 mM NaCl before incubation with substrates. For the pentaketide-PikAIII state, 1 mM holo-PikAIII was incubated with 1 mM thiophenol-activated pentaketide 11 for 30 min at room temperature. For the b-ketohexaketide-PikAIII state, 1 mM holo-PikAIII was incubated with 500 mM MM-CoA and 1 mM thiophenolactivated pentaketide for 30 min at room temperature. For the b-hydroxyhexaketide-PikAIII state, 1 mM holo-PikAIII was incubated with 1 mM NADPH for 10 min at room temperature followed by incubation with 500 mM MM-CoA and 1 mM thiophenol-activated pentaketide for 30 min at room temperature. Mass spectrometric analysis of active site occupancy. Bottom-up liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry (LC/ FT-ICR MS) was used to confirm the presence or absence of substrate in each domain of pentaketide-PikAIII, b-ketohexaketide-PikAIII and b-hydroxyhexaketide-PikAIII. Loading reactions were as described earlier except 2 mM holo-PikAIII was used and substrate concentrations were increased accordingly. Twenty-five microlitres of each loading reaction were diluted with 20 ml 250 mM ammonium bicarbonate (pH 8.0). Trypsin in 50 mM acetic acid was added in an enzyme:substrate ratio of 1:10. Proteolysis was allowed to proceed for 15 min at 37 uC followed by addition of formic acid (pH 4). Samples were stored at 220 uC until analysis.
Forty-five microliters of sample were injected onto a Synergi Hydro C18 hydrophilically endcapped 1 3 150 mm column with 4 mm particles (Phenomenex). A gradient was generated on an Agilent 1100 HPLC. The gradient was as follows (with isocratic elution between 40 and 50 min): 0 (98,2), 20 (70,30), 40 (50,50), 50 (50,50), 55 (30, 70) , 70 (2, 98) . Values are provided as time (%A, %B) over a total run time of 90 min. Flow was at 50 ml min 21 and was diverted for the first 5 min of the run. Buffer A was 0.1% formic acid (ThermoFisher Scientific) in HPLC-grade water (ThermoFisher Scientific), and buffer B was 0.1% formic acid in acetonitrile (ThermoFisher Scientific). The LC was coupled to a quadrupole FTICR-MS (SolariX with 7T magnet, Bruker Daltonics). Data were gathered from m/z 200-2,000 in positive ion mode. Electrospray was conducted at 4,500 V with four scans per spectrum and a 256k transient. External ion accumulation in a hexapole was 0.2 s and there was 1 ICR fill before excitation and detection. External calibration used HPmix (Agilent). PikAIII peptide products were detected over three samples in separate runs. Sample preparation and cryo-EM imaging. Sample quality and homogeneity was evaluated by conventional negative staining 29 . For cryo-EM, sample preparation and image acquisition was performed as described in the accompanying paper 2 . Substrate incubation conditions for each sample characterized by cryo-EM are described earlier.
Image processing and three-dimensional reconstructions. Cryo-EM image processing and three-dimensional reconstructions were performed as described in the accompanying paper 2 using EMAN (1.9) 30 . A 30 Å low-pass filtered map of MM-PikAIII 2 was used as the initial model for iterative projection matching and three-dimensional reconstructions of pentaketide-PikAIII. The final map of pentaketide-PikAIII was filtered to 30 Å and used as the initial reference for threedimensional reconstructions of b-ketohexaketide-PikAIII and for all three conformations of b-hydroxyhexaketide-PikAIII. All refinements were performed based on the same procedure described in the accompanying paper 2 and with final angular steps of 2-5u. The numbers of particle projections used for the final three-dimensional reconstructions are listed in Extended Data Fig. 2d .
In initial reconstructions of b-hydroxyhexaketide-PikAIII we observed three separate densities corresponding to the ACP, all attached at the bottom of KR and outside of the reaction chamber. To separate the particle projections corresponding to each ACP state we employed multiple-reference-supervised classification 21, 22 . To this end we produced three initial models that differed only in the ACP position by docking the structures of DEBS module 5 KS and AT 12 , DEBS module 1 KR 13 and DEBS module 2 ACP 14 in the corresponding densities of the initial reconstruction. We proceeded with multiple-reference-supervised classification by subjecting the full data set of 56,429 projections to the multirefine routine in EMAN (1.9) 30 using the three above models as references. In this way the particle projections were classified into three categories according to their cross-correlation with reprojections of the three references of b-hydroxyhexaketide-PikAIII. The number of particles in each category is provided in Extended Data Fig. 2d . In the next step, we used the separated particle data sets to calculate the three independent threedimensional reconstructions using the 30 Å low-pass filtered EM map of pentaketide-PikAIII as an initial reference, as described earlier.
The validation of the reconstruction scheme and EM maps has been extensively described in the accompanying manuscript 2 . Besides the conventional full data set refinements we additionally ran independent gold-standard 31 refinements of half data for pentaketide-PikAIII and b-ketohexaketide-PikAIII, employing 50 Å filtered EM maps as an initial reference. Resolution calculations were based on conventional 'even/odd' Fourier shell correlation (FSC) and also gold-standard FSC measurements in EMAN. The FSC plots for all three-dimensional reconstructions are provided in Extended Data Fig. 2 . Briefly, the gold-standard procedure shows a resolution of 7.9 Å for pentaketide-PikAIII and 8.2 Å for b-ketohexaketide-PikAIII at FSC 5 0.143 (ref. 31) , in good agreement with the conventional 0.5 FSC values of 7.9 Å and 7.8 Å , respectively (Extended Data Fig. 2a, b, d) . Consistent with these measurements, the agreement between the map from the conventional procedure and the map resulting from averaging the two gold-standard half-maps 32 of pentaketide-PikAIII and b-ketohexaketide-PikAIII extends to 8.0 Å and 8.2 Å at 0.5 FSC, respectively (Extended Data Fig. 2d ). Gold-standard resolution calculations were not performed for the three b-hydroxyhexaketide-PikAIII conformer maps owing to the limited number projections included in half-data sets (Extended Data Fig. 2d ). The resolution of the b-hydroxyhexaketide-PikAIII conformer i, ii and iii maps was assessed by conventional FSC measurements and was found to be 10.7 Å , 11.0 Å and 11.6 Å with the 0.5 FSC criterion, respectively (Extended Data Fig. 2c, d ). Finally, we applied high-resolution phase randomization tests 33 for pentaketide-PikAIII and b-ketohexaketide-PikAIII reconstructions and did not detect any obvious over-fitting (noise refinement) (Extended Data Fig. 2a, b) . Thus, independent FSC calculations and phase randomization tests exclude any detectable map overrefinement (see also ref. 2). The final three-dimensional EM maps were sharpened using EMBFACTOR 34, 35 and subsequently filtered according to their indicated resolution range. Modelling and map visualization. The crystal structures of DEBS module 5 KS dimer (Protein Data Bank (PDB) accession 2HG4) 12 , AT monomer (PDB accession 2HG4) 12 and DEBS module 1 KR monomer (PDB accession 2FR0) 13 , and the NMR structure of DEBS module 2 ACP (PDB accession 2JU1) 14 , were independently fit in the EM maps as rigid bodies using the fit in map routine in CHIMERA 36 (for details see the accompanying paper 2 ). As the PikAIII KR 5 domain is an A-type KR, we fit crystal structures of both an A-type 37 and a B-type KR 13 to the EM density. The highly similar KRs both fit well, but the B-type KR was a better fit in regions with low sequence identity and was used for all models. Enzyme assays. PikAIII-TE and PikAIII/PikAIV assays were described previously 15, 16 . Either 1 mM PikAIII-TE or 1 mM PikAIII and 1 mM PikAIV was added to a 100 ml reaction mixture containing 0.5 mM NADP 1 , 0.5 U ml 21 glucose-6-phosphate dehydrogenase, 5 mM glucose-6-phosphate in 400 mM sodium phosphate pH 7.2, 20% glycerol, 5 mM NaCl. This mixture was incubated for 10 min at room temperature and the reaction was initiated by addition of 1 mM thiophenol-activated pentaketide 11 , 8 mM 2-vinylpyridine and 20 mM MM-N-acetyl cysteamine (NAC). Following a 1 h incubation at room temperature, the reaction was quenched by addition of a threefold excess of methanol, vortexed, incubated for 15 min at 220 uC, and centrifuged. The supernatant was analysed by reverse-phase HPLC on a Luna
